Related Experiment Video
Updated: May 8, 2026

Hybrid Ensemble and Single-molecule Assay to Image the Motion of Fully Reconstituted CMG
Published on: July 26, 2024
Ciprofloxacin is an inhibitor of the Mcm2-7 replicative helicase
Nicholas Simon1, Matthew L Bochman, Sandlin Seguin1
1*Department of Biological Sciences, University of Pittsburgh, Pittsburgh, PA 15260, U.S.A.
Abstract:
Most currently available small molecule inhibitors of DNA replication lack enzymatic specificity, resulting in deleterious side effects during use in cancer chemotherapy and limited experimental usefulness as mechanistic tools to study DNA replication. Towards development of targeted replication inhibitors, we have focused on Mcm2-7 (minichromosome maintenance protein 2-7), a highly conserved helicase and key regulatory component of eukaryotic DNA replication. Unexpectedly we found that the fluoroquinolone antibiotic ciprofloxacin preferentially inhibits Mcm2-7. Ciprofloxacin blocks the DNA helicase activity of Mcm2-7 at concentrations that have little effect on other tested helicases and prevents the proliferation of both yeast and human cells at concentrations similar to those that inhibit DNA unwinding. Moreover, a previously characterized mcm mutant (mcm4chaos3) exhibits increased ciprofloxacin resistance. To identify more potent Mcm2-7 inhibitors, we screened molecules that are structurally related to ciprofloxacin and identified several that compromise the Mcm2-7 helicase activity at lower concentrations. Our results indicate that ciprofloxacin targets Mcm2-7 in vitro, and support the feasibility of developing specific quinolone-based inhibitors of Mcm2-7 for therapeutic and experimental applications.
Insights
The antibiotic ciprofloxacin specifically inhibits the Mcm2-7 helicase, a key DNA replication protein. This finding supports developing targeted Mcm2-7 inhibitors for cancer therapy and research.
Area of Science:
- Molecular Biology
- Biochemistry
- Genetics
Background:
- Current DNA replication inhibitors lack specificity, causing side effects and limiting research utility.
- Targeting specific components like Mcm2-7 is crucial for developing precise inhibitors.
Purpose of the Study:
- To identify specific inhibitors of the Mcm2-7 helicase, a core component of DNA replication.
- To explore the potential of ciprofloxacin and related compounds as Mcm2-7 inhibitors.
Main Methods:
- Enzyme assays to test ciprofloxacin's effect on Mcm2-7 helicase activity.
- Cell proliferation assays in yeast and human cells.
- Screening of ciprofloxacin analogs for enhanced Mcm2-7 inhibition.
Main Results:
- Ciprofloxacin selectively inhibits Mcm2-7 helicase activity in vitro.
- Inhibition of Mcm2-7 by ciprofloxacin correlates with reduced cell proliferation.
- A specific mcm mutant displayed resistance to ciprofloxacin, confirming target engagement.
Conclusions:
- Ciprofloxacin is a specific inhibitor of the Mcm2-7 helicase.
- Quinolone-based compounds show promise for developing targeted Mcm2-7 inhibitors for therapeutic and research applications.
Related Concept Videos
Inhibitors of Bacterial DNA Synthesis
DNA Helicases
Inhibitors of Bacterial Protein Synthesis
Restarting Stalled Replication Forks
Anaphase Promoting Complex
S-Cdk Initiates DNA Replication
Two states at the origin of replication
In eukaryotes, the initiation of replication occurs at many sites on the chromosomes, called the origins of replication.

